2
Ma et al. Sci China Chem June (2015) Vol.58 No.6
from tertiary amines, in which various carbonyl sources
could be applied for tertiary amide synthesis.
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.18 (d, J=7.8 Hz, 2H), 7.04 (d, J=7.6 Hz, 2H),
3.21 (s, 3H), 2.35 (s, 3H), 1.83 (s, 3H). 13C NMR (100 MHz,
CDCl3) 170.7, 142.0, 137.5, 130.2, 126.7, 37.1, 22.2,
20.9.
2 Experimental
2.2.3 N-methyl-N-(p-tolyl)propionamide (3c)
2.1 General information
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.21 (d, J=8.0 Hz, 2H), 7.06 (d, J=8.1 Hz, 2H),
3.24 (s, 3H), 2.37 (s, 3H), 2.08 (q, J=7.4 Hz, 2H), 1.04 (t,
J=7.5 Hz, 3H). 13C NMR (100 MHz, CDCl3) 174.2, 141.6,
137.6, 130.3, 127.0, 37.3, 27.4, 21.0, 9.7.
1H NMR spectra were recorded on Bruker 400 MHz spec-
trometer (Switzerland) and the chemical shifts were report-
ed in parts per million () relative to internal standard TMS
(0 ppm) for CDCl3. The peak patterns are indicated as fol-
lows: s, singlet; d, doublet; dd, doublet of doublet; t, triplet;
m, multiplet; q, quartet. The coupling constants, J, are re-
ported in Hertz (Hz). 13C NMR spectra were obtained at
Bruker 100 MHz and referenced to the internal solvent sig-
nals (central peak is 77.0 ppm in CDCl3). CDCl3 was used
as the NMR solvent. Mass spectra were obtained on a VG
ZAB-HS mass spectrometer. APEX II (Bruker Inc., Swit-
zerland) was used for HR-MS and ESI-MS. IR spectra were
recorded by a Nicolet 5MX-S infrared spectrometer (Ther-
mo Electron, USA). Flash column chromatography was
performed over silica gel 200–300. All reagents were
weighed and handled in air at room temperature. Unless
otherwise noted, all reactions were performed under a ni-
trogen atmosphere. All reagents were purchased from Alfa
(USA), Acros (Belgium), Aldrich (USA), and TCI (Japan)
and used without further purification.
2.2.4 N-methyl-N-(p-tolyl)benzamide (3d)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.33–7.27 (m, 2H), 7.23 (m, 1H), 7.17 (m, 2H),
7.01 (d, J=8.1 Hz, 2H), 6.91 (d, J=8.2 Hz, 2H), 3.47 (s, 3H),
2.26 (s, 3H). 13C NMR (100 MHz, CDCl3) 170.6, 142.3,
136.2, 129.8, 129.7, 129.4, 128.6, 127.6, 126.6, 38.4, 20.9.
2.2.5 N,4-dimethyl-N-(p-tolyl)benzamide (3e)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.20 (d, J=8.1 Hz, 2H), 7.01 (d, J=8.2 Hz, 2H),
6.96 (d, J=7.9 Hz, 2H), 6.92 (d, J=8.3 Hz, 2H), 3.46 (s, 3H),
2.27 (s, 3H), 2.23 (s, 3H). 13C NMR (100 MHz, CDCl3)
170.7, 142.5, 139.6, 136.1, 132.9, 129.7, 128.8, 128.3,
126.6, 38.6, 21.3, 20.9.
2.2 Synthesis and characterization of the products 3
To a mixture of amine 1 (0.5 mmol), pivalic anhydride (1.0
mmol), carboxylic acid 2 (1.0 mmol), and FeCl3·6H2O (0.1
mmol), toluene (2.0 mL) was added under nitrogen at room
temperature. Nitrogen flow was closed and oxygen was then
introduced into the Schlenk tube via a needle from an oxy-
gen balloon. The resulting mixture was stirred under 85 °C
for 24 h. The temperature of reaction was cooled to room
temperature and the solvent was evaporated in vacuo. The
residue was purified by flash column chromatography on
silica gel with ethyl acetate/petroleum ether (v/v=1:10) as an
eluent to afford the pure product 3 [8].
2.2.6 N-methyl-4-nitro-N-(p-tolyl)benzamide (3f)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 8.02 (d, J=8.6 Hz, 2H), 7.45 (d, J=8.6 Hz, 2H),
7.02 (d, J=7.8 Hz, 2H), 6.91 (d, J=7.8 Hz, 2H), 3.49 (s, 3H),
2.27 (s, 3H). 13C NMR (100 MHz, CDCl3) 168.3, 147.8,
142.2, 141.1, 137.2, 130.1, 129.4, 126.6, 122.9, 38.2, 20.8.
2.2.7 N-methyl-N-(p-tolyl)cyclopentanecarboxamide (3g)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.21 (d, J=8.1 Hz, 2H), 7.10 (d, J=8.2 Hz, 2H),
4.32 (m, 1H), 4.08–3.99 (m, 1H), 3.86–3.75 (m, 1H), 3.24 (s,
3H), 2.38 (s, 3H), 2.10–1.96 (m, 2H), 1.91–1.68 (m, 2H).
13C NMR (100 MHz, CDCl3) 172.8, 140.5, 137.8, 130.2,
127.2, 74.7, 69.4, 37.7, 30.1, 25.9, 21.0.
2.2.1 N-methyl-N-(p-tolyl)hexanamide (3a)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.4). 1H NMR (400 MHz,
CDCl3) 7.21 (d, J=8.0 Hz, 2H), 7.05 (d, J=8.2 Hz, 2H),
3.24 (s, 3H), 2.38 (s, 3H), 2.06 (t, J=7.6 Hz, 2H), 1.63–1.49
(m, 2H), 1.27–1.05 (m, 4H), 0.83 (t, J=7.0 Hz, 3H). 13C
NMR (100 MHz, CDCl3) 173.4, 141.6, 137.4, 130.2,
127.0, 37.2, 33.9, 31.4, 25.2, 22.3, 21.0, 13.8 (see the
Supporting Information online).
2.2.8 N-methyl-N-(p-tolyl)cyclopentanecarboxamide (3h)
Isolated by flash column chromatography (ethyl acetate/
petroleum ether, v/v=1:2, Rf=0.3). 1H NMR (400 MHz,
CDCl3) 7.20 (d, J=8.1 Hz, 2H), 7.04 (d, J=8.1 Hz, 2H),
3.21 (s, 3H), 2.38, (s, 3H), 2.28–2.33 (m, 1H), 1.41–1.57 (m,
1H), 0.90–1.01 (m, 1H). 13C NMR (100 MHz, CDCl3)
2.2.2 N-methyl-N-(p-tolyl)acetamide (3b)
Isolated by flash column chromatography (ethyl acetate/